The genetics of malignant melanoma: lessons from mouse and man (original) (raw)

• Norris, W. A case of fungoid disease. Edinburgh Medicine and Surgery 16, 562–565 (1820).
  Google Scholar
• Armstrong, B. K. & Kricker, A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B. 63, 8–18 (2001).
  Article CAS PubMed Google Scholar
• Gilchrest, B. A., Eller, M. S., Geller, A. C. & Yaar, M. The pathogenesis of melanoma induced by ultraviolet radiation. N. Engl. J. Med. 340, 1341–1348 (1999).
  Article CAS PubMed Google Scholar
• Marrett, L. D., Nguyen, H. L. & Armstrong, B. K. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996. Int. J. Cancer 92, 457–462 (2001).
  Article CAS PubMed Google Scholar
• Fountain, J. W., Bale, S. J., Housman, D. E. & Dracopoli, N. C. Genetics of melanoma. Cancer Surv. 9, 645–671 (1990).
  CAS PubMed Google Scholar
• Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994). References 6 and 7 identified CDKN2A as the tumour-suppressor gene deleted at the 9p21 cancer hot spot.
  Article CAS PubMed Google Scholar
• Hussussian, C. J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15–21 (1994).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 23–26 (1994). References 8 and 9 were the first to report germline mutation of CDKN2A in familial-melanoma kindred, linking cell-cycle dysregulation to hereditary cancer predisposition.
  Article CAS PubMed Google Scholar
• Kamb, A. Cell-cycle regulators and cancer. Trends Genet. 11, 136–140 (1995).
  Article CAS PubMed Google Scholar
• Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000 (1995). This paper reports the discovery of an alternative product, ARF, at the CDKN2A locus, which negatively regulates the cell cycle with a mechanism that is distinct from that of the cyclin-dependent kinase inhibitor INK4A.
  Article CAS PubMed Google Scholar
• Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
  Article CAS PubMed Google Scholar
• Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292–8297 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713–723 (1998).
  Article CAS PubMed Google Scholar
• Stott, F. J. et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001–5014 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y., Xiong, Y. & Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725–734 (1998). References 13 to 16 report the elucidation of the biochemical link between ARF and p53 via its interaction with MDM2.
  Article CAS PubMed Google Scholar
• Glendening, J. M. et al. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res. 55, 5531–5535 (1995).
  CAS PubMed Google Scholar
• Aitken, J. et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. J. Natl Cancer Inst. 91, 446–452 (1999).
  Article CAS PubMed Google Scholar
• Tsao, H. et al. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch. Dermatol. 136, 1118–1122 (2000).
  Article CAS PubMed Google Scholar
• Liu, L. et al. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nature Genet. 21, 128–132 (1999).
  Article PubMed CAS Google Scholar
• Kumar, R. et al. A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int. J. Cancer 95, 388–393 (2001).
  Article CAS PubMed Google Scholar
• Wolfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284 (1995).
  Article CAS PubMed Google Scholar
• Zuo, L. et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genet. 12, 97–99 (1996).
  Article CAS PubMed Google Scholar
• Soufir, N. et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum. Mol. Genet. 7, 209–216 (1998).
  Article CAS PubMed Google Scholar
• Tsao, H., Benoit, E., Sober, A. J., Thiele, C. & Haluska, F. G. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene. Cancer Res. 58, 109–113 (1998). References 22 to 25 report the finding of R24 mutations in familial and sporadic human melanomas that render CDK4 insensitive to regulation by INK4A.
  CAS PubMed Google Scholar
• Russo, A. A., Tong, L., Lee, J. O., Jeffrey, P. D. & Pavletich, N. P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395, 237–243 (1998).
  Article CAS PubMed Google Scholar
• Goldstein, A. M., Struewing, J. P., Chidambaram, A., Fraser, M. C. & Tucker, M. A. Genotype–phenotype relationships in U. S. melanoma-prone families with CDKN2A and CDK4 mutations. J. Natl Cancer Inst. 92, 1006–1010 (2000).
  Article CAS PubMed Google Scholar
• Sotillo, R. et al. Invasive melanoma in Cdk4-targeted mice. Proc. Natl Acad. Sci. USA 98, 13312–13317 (2001). This study recapitulates the melanoma-prone effect of the Cdk4 R24C mutation in a mouse model.
  Article CAS PubMed PubMed Central Google Scholar
• Ruas, M. & Peters, G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, F115–F177 (1998).
  CAS PubMed Google Scholar
• Piccinin, S. et al. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int. J. Cancer 74, 26–30 (1997).
  Article CAS PubMed Google Scholar
• Straume, O., Smeds, J., Kumar, R., Hemminki, K. & Akslen, L. A. Significant impact of promoter hypermethylation and the 540 C→T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am. J. Pathol. 161, 229–237 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kumar, R., Sauroja, I., Punnonen, K., Jansen, C. & Hemminki, K. Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines. Genes Chromosomes Cancer 23, 273–277 (1998).
  Google Scholar
• Randerson-Moor, J. A. et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma–neural system tumour syndrome family. Hum. Mol. Genet. 10, 55–62 (2001).
  Article CAS PubMed Google Scholar
• Rizos, H. et al. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 20, 5543–5547 (2001). References 33 and 34 identified germline ARF mutations in human melanoma patients.
  Article CAS PubMed Google Scholar
• Duro, D., Bernard, O., Della Valle, V., Berger, R. & Larsen, C. J. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11, 21–29 (1995).
  CAS PubMed Google Scholar
• Mao, L. et al. A novel p16INK4a transcript. Cancer Res. 55, 2995–2997 (1995).
  CAS PubMed Google Scholar
• Stone, S. et al. Complex structure and regulation of the p16(MTS1) locus. Cancer Res. 55, 2988–2994 (1995). References 35 to 37, as well as reference 11, describe the conserved genomic organization of the CDKN2A locus from opossum to man.
  CAS PubMed Google Scholar
• Swafford, D. S. et al. Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol. Cell Biol. 17, 1366–1374 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sherburn, T. E., Gale, J. M. & Ley, R. D. Cloning and characterization of the CDKN2A and p19ARF genes from Monodelphis domestica. DNA Cell Biol. 17, 975–981 (1998).
  Article CAS PubMed Google Scholar
• Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
  Article CAS PubMed Google Scholar
• Chin, L. et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11, 2822–2834 (1997). References 40 and 41 provide genetic proof in the mouse that the Cdkn2a locus functions as a bona fide tumour suppressor, specifically of melanoma, in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Yang, F. C., Merlino, G. & Chin, L. Genetic dissection of melanoma pathways in the mouse. Semin. Cancer Biol. 11, 261–268 (2001).
  Article CAS PubMed Google Scholar
• Bradl, M., Klein-Szanto, A., Porter, S. & Mintz, B. Malignant melanoma in transgenic mice. Proc. Natl Acad. Sci. USA 88, 164–168 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Bardeesy, N. et al. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol. Cell Biol. 21, 2144–2153 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell Biol. 19, 1–11 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Ross, D. A. & Wilson, G. D. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br. J. Surg. 85, 46–51 (1998).
  Article CAS PubMed Google Scholar
• Kraehn, G. M. et al. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br. J. Cancer 84, 72–79 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R. & Lowe, S. W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670–2677 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sharpless, N. E. et al. p16INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res. 62, 2761–2765 (2002).
  CAS PubMed Google Scholar
• Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A. & Berns, A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83–86 (2001).
  Article CAS PubMed Google Scholar
• Sharpless, N. E. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86–91 (2001). References 50 and 51 show that Ink4a functions as a tumour suppressor in the mouse, as it does in humans.
  Article CAS PubMed Google Scholar
• Sharpless, N. E. et al. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene (in the press).
• Valverde, P., Healy, E., Jackson, I., Rees, J. L. & Thody, A. J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet. 11, 328–330 (1995).
  Article CAS PubMed Google Scholar
• Sturm, R. A. Skin colour and skin cancer: MC1R, the genetic link. Melanoma Res. 12, 405–416 (2002).
  Article CAS PubMed Google Scholar
• Box, N. F., Wyeth, J. R., O'Gorman, L. E., Martin, N. G. & Sturm, R. A. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 1891–1897 (1997).
  Article CAS PubMed Google Scholar
• Smith, R. et al. Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111, 119–122 (1998).
  Article CAS PubMed Google Scholar
• Flanagan, N. et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum. Mol. Genet. 9, 2531–2537 (2000).
  Article CAS PubMed Google Scholar
• Palmer, J. S. et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176–186 (2000).
  Article CAS PubMed Google Scholar
• Bastiaens, M. et al. The melanocortin-1-receptor gene is the major freckle gene. Hum. Mol. Genet. 10, 1701–1708 (2001).
  Article CAS PubMed Google Scholar
• Box, N. F. et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 69, 765–773 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Healy, E. et al. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 1072–1073 (2000).
  Article CAS PubMed Google Scholar
• Busca, R. & Ballotti, R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60–69 (2000).
  Article CAS PubMed Google Scholar
• Wildlund, H. R. & Fisher, D. E. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 22, 3035–3041 (2003).
  Article CAS Google Scholar
• Harsanyi, Z. P., Post, P. W., Brinkmann, J. P., Chedekel, M. R. & Deibel, R. M. Mutagenicity of melanin from human red hair. Experientia 36, 291–292 (1980).
  Article CAS PubMed Google Scholar
• Scott, M. C. et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 2349–2355 (2002).
  Article CAS PubMed Google Scholar
• Kennedy, C. et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294–300 (2001).
  Article CAS PubMed Google Scholar
• van der Velden, P. A. et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am. J. Hum. Genet. 69, 774–779 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hayward, N. K. Genetics of melanoma predisposition. Oncogene 22, 3053–3062 (2003).
  Article CAS PubMed Google Scholar
• Johnson, G. L. & Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911–1912 (2002).
  Article CAS PubMed Google Scholar
• Yanase, H. et al. Possible involvement of ERK 1/2 in UVA-induced melanogenesis in cultured normal human epidermal melanocytes. Pigment Cell Res. 14, 103–109 (2001).
  Article CAS PubMed Google Scholar
• Busca, R. et al. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19, 2900–2910 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lowes, V. L., Ip, N. Y. & Wong, Y. H. Integration of signals from receptor tyrosine kinases and g protein-coupled receptors. Neurosignals 11, 5–19 (2002).
  Article CAS PubMed Google Scholar
• Imokawa, G., Yada, Y. & Miyagishi, M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biochem. 267, 24675–24680 (1992).
  CAS Google Scholar
• Gilchrest, B. A., Park, H. Y., Eller, M. S. & Yaar, M. Mechanisms of ultraviolet light-induced pigmentation. Photochem. Photobiol. 63, 1–10 (1996).
  Article CAS PubMed Google Scholar
• Tada, A. et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ. 9, 575–584 (1998).
  CAS PubMed Google Scholar
• Nesbit, M. et al. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18, 6469–6476 (1999).
  Article CAS PubMed Google Scholar
• Dupin, E. & Le Douarin, N. M. Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22, 3016–3023 (2003).
  Article CAS PubMed Google Scholar
• Jafari, M. et al. Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J. Cancer Res. Clin. Oncol. 121, 23–30 (1995).
  Article CAS PubMed Google Scholar
• van Elsas, A. et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am. J. Pathol. 149, 883–893 (1996).
  CAS PubMed PubMed Central Google Scholar
• Papp, T. et al. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 36, 610–614 (1999).
  CAS PubMed PubMed Central Google Scholar
• Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C. & van den Oord, J. J. Analysis of _N_- and K-ras mutations in the distinctive tumor progression phases of melanoma. J. Invest. Dermatol. 117, 1483–1489 (2001).
  Article CAS PubMed Google Scholar
• Albino, A. P. et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 4, 1363–1374 (1989).
  CAS PubMed Google Scholar
• Papp, T. et al. Mutational analysis of N–ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi. J. Med. Genet. 40, E14 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bastian, B. C. et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 60, 1968–1973 (2000).
  CAS PubMed Google Scholar
• Powell, M. B. et al. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter. Mol. Carcinog. 12, 82–90 (1995).
  Article CAS PubMed Google Scholar
• Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002). This is a seminal study that not only identifies BRAF as a frequently mutated gene in human cancers, particularly in melanoma, but also serves as the proof-of-principle demonstration of the power of genome sequencing as a gene-discovery platform.
  Article CAS PubMed Google Scholar
• Rajagopalan, H. et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418, 934 (2002).
  Article CAS PubMed Google Scholar
• Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nature Genet. 33, 19–20 (2003).
  Article CAS PubMed Google Scholar
• Cohen, C. et al. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin. Cancer Res. 8, 3728–3733 (2002).
  CAS PubMed Google Scholar
• Bottaro, D. P. et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802–804 (1991).
  Article CAS PubMed Google Scholar
• Vande Woude, G. F. et al. Met-HGF/SF: tumorigenesis, invasion and metastasis. Ciba Found. Symp. 212, 119–130 (1997).
  CAS PubMed Google Scholar
• Li, G. et al. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 20, 8125–8135 (2001).
  Article CAS PubMed Google Scholar
• Halaban, R. et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7, 2195–2206 (1992).
  CAS PubMed Google Scholar
• Natali, P. G. et al. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer 68, 746–750 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Wiltshire, R. N. et al. Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res. 55, 3954–3957 (1995).
  CAS PubMed Google Scholar
• Bastian, B. C., LeBoit, P. E., Hamm, H., Brocker, E. B. & Pinkel, D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 58, 2170–2175 (1998).
  CAS PubMed Google Scholar
• Rusciano, D., Lorenzoni, P. & Burger, M. M. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization. Oncogene 11, 1979–1987 (1995).
  CAS PubMed Google Scholar
• Otsuka, T. et al. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res. 58, 5157–5167 (1998).
  CAS PubMed Google Scholar
• Wu, H., Goel, V. & Haluska, F. G. PTEN signaling pathways in melanoma. Oncogene 22, 3113–3122 (2003).
  Article CAS PubMed Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998).
  Article CAS PubMed Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
  Article CAS PubMed Google Scholar
• Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356–362 (1997).
  Article CAS PubMed Google Scholar
• Li, D. M. & Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57, 2124–2129 (1997).
  CAS PubMed Google Scholar
• Guldberg, P. et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57, 3660–3663 (1997).
  CAS PubMed Google Scholar
• Teng, D. H. et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221–5225 (1997).
  CAS PubMed Google Scholar
• Robertson, G. P. et al. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc. Natl Acad. Sci. USA 95, 9418–9423 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hwang, P. H. et al. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett. 172, 83–91 (2001).
  Article CAS PubMed Google Scholar
• Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64–67 (1997).
  Article CAS PubMed Google Scholar
• Marsh, D. J. et al. Germline mutations in PTEN are present in Bannayan–Zonana syndrome. Nature Genet. 16, 333–334 (1997).
  Article CAS PubMed Google Scholar
• Nelen, M. R. et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 6, 1383–1387 (1997).
  Article CAS PubMed Google Scholar
• Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998).
  Article CAS PubMed Google Scholar
• Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563–1568 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169–1178 (1998).
  Article CAS PubMed Google Scholar
• You, M. J. et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc. Natl Acad. Sci. USA 99, 1455–1460 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Schreiber-Agus, N. et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483–487 (1998).
  Article CAS PubMed Google Scholar
• Holman, C. D. & Armstrong, B. K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J. Natl Cancer Inst. 73, 75–82 (1984).
  CAS PubMed Google Scholar
• Autier, P. & Dore, J. F. Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int. J. Cancer 77, 533–537 (1998).
  Article CAS PubMed Google Scholar
• Whiteman, D. C., Whiteman, C. A. & Green, A. C. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12, 69–82 (2001).
  Google Scholar
• Atillasoy, E. S. et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am. J. Pathol. 152, 1179–1186 (1998).
  CAS PubMed PubMed Central Google Scholar
• Berking, C. et al. Photocarcinogenesis in human adult skin grafts. Carcinogenesis 23, 181–187 (2002).
  Article CAS PubMed Google Scholar
• Jamal, S. & Schneider, R. J. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J. Clin. Invest. 110, 443–452 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Donawho, C. K. & Kripke, M. L. Evidence that the local effect of ultraviolet radiation on the growth of murine melanomas is immunologically mediated. Cancer Res. 51, 4176–4181 (1991).
  CAS PubMed Google Scholar
• Pollock, P. M., Pearson, J. V. & Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 15, 77–88 (1996).
  Google Scholar
• Peris, K. et al. UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas. J. Invest. Dermatol. 112, 825–826 (1999).
  Article CAS PubMed Google Scholar
• Kyritsis, A. P. et al. Mutations of the p16 gene in gliomas. Oncogene 12, 63–67 (1996).
  CAS PubMed Google Scholar
• de Gruijl, F. R., van Kranen, H. J. & Mullenders, L. H. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J. Photochem. Photobiol. B. 63, 19–27 (2001).
  Article CAS PubMed Google Scholar
• Horiguchi, M. et al. Molecular nature of ultraviolet B light-induced deletions in the murine epidermis. Cancer Res. 61, 3913–3918 (2001).
  CAS PubMed Google Scholar
• Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415–428 (2002).
  Article CAS PubMed Google Scholar
• Noonan, F. P. et al. Neonatal sunburn and melanoma in mice. Nature 413, 271–272 (2001). This report provides the first experimental support for the long-held epidemiological observation that childhood sunburn confers a higher risk for melanoma development.
  Article CAS PubMed Google Scholar
• Noonan, F. P., Otsuka, T., Bang, S., Anver, M. R. & Merlino, G. Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res. 60, 3738–3743 (2000).
  CAS PubMed Google Scholar
• Recio, J. A. et al. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res. 62, 6724–6730 (2002).
  CAS PubMed Google Scholar
• Kannan, K. et al. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Pro. Natl Acad. Sci. USA 100, 1221–1225 (2003). This paper reports genetic studies in the mouse that identify the Rb-pathway components (Ink4a and Cdk6) as key targets of the melanoma-promoting effect of UV light.
  Article CAS Google Scholar
• Bishop, D. T. et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94, 894–903 (2002).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001).
  Article CAS PubMed Google Scholar
• Demetri, G. D. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472–480 (2002).
  Article CAS PubMed Google Scholar
• Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876–880 (2001).
  Article CAS PubMed Google Scholar
• Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nature Rev. Cancer 3, 375–380 (2003).
  Article CAS Google Scholar
• Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468–472 (1999). This study is the first to show the use of an inducible onco-transgene model to study tumour maintenance.
  Article CAS PubMed Google Scholar
• Streit, M. & Detmar, M. Angiogenesis, lymphangiogenesis and melanoma metastasis. Oncogene 22, 3172–3179 (2003).
  Article CAS PubMed Google Scholar
• Hsu, M. Y., Wheelock, M. J., Johnson, K. R. & Herlyn, M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investig. Dermatol. Symp. Proc. 1, 188–194 (1996).
  CAS PubMed Google Scholar
• Hsu, M. Y. et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515–1525 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  Article CAS PubMed Google Scholar
• DePinho, R. A. Transcriptional repression: The cancer-chromatin connection. Nature 391, 533–536 (1998).
  Article CAS PubMed Google Scholar
• Quelle, D. E., Cheng, M., Ashmun, R. A. & Sherr, C. J. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc. Natl Acad. Sci. USA 94, 669–673 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• de Stanchina, E. et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434–2442 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Radfar, A., Unnikrishnan, I., Lee, H. W., DePinho, R. A. & Rosenberg, N. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc. Natl Acad. Sci. USA 95, 13194–13199 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37–40 (2001).
  Article CAS PubMed Google Scholar
• Bennett, D. C. Genetics, development, and malignancy of melanocytes. Int. Rev. Cytol. 146, 191–260 (1993).
  Article CAS PubMed Google Scholar
• Jimbow, K., Quevedo W. C. Jr, Fitzpatrick, T. & Szabo, G. in Dermatology in General Medicine (eds. Fitzpatrick, T. B. et al.) 261–289 (McGraw-Hill, Inc, New York, 1993).
  Google Scholar
• Hsu, M. Y., Meier, F. & Herlyn, M. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70, 522–536 (2002).
  Article CAS PubMed Google Scholar
• Balch, C. M. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19, 3622–3634 (2001).
  Article CAS PubMed Google Scholar
• Latres, E. et al. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496–3506 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Walker, G. J. et al. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22, 157–163 (1998).
  Google Scholar
• Flores, J. F. et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res. 56, 5023–5032 (1996).
  CAS PubMed Google Scholar
• Fujimoto, A., Morita, R., Hatta, N., Takehara, K. & Takata, M. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma. Oncogene 18, 2527–2532 (1999).
  Article CAS PubMed Google Scholar
• Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock? Cell 102, 407–410 (2000).
  Article CAS PubMed Google Scholar
• Blackwell, T. K. & Weintraub, H. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250, 1104–1110 (1990).
  Article CAS PubMed Google Scholar
• Bertolotto, C. et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827–835 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Price, E. R. et al. α-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem. 273, 33042–33047 (1998).
  Article CAS PubMed Google Scholar
• Brose, M. S. et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 62, 6997–7000 (2002).
  CAS PubMed Google Scholar
• Naoki, K., Chen, T. H., Richards, W. G., Sugarbaker, D. J. & Meyerson, M. Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res. 62, 7001–7003 (2002).
  CAS PubMed Google Scholar
• Hamad, N. M. et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16, 2045–2057 (2002).
  Article CAS PubMed PubMed Central Google Scholar